Orencia Sc 125 Mg 125 mg Solution for subcutaneous injection
PDF Leaflet Revision Date: 21 February 2023
Clinical Summary
Quick overview from the medicine insert
Indication
For adult rheumatoid arthritis to reduce symptoms and improve function.
Dosage (summary)
125 mg subcutaneously weekly; IV loading dose may be used.
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not recommended during pregnancy or breastfeeding.
Key Drug Interactions
- TNF blocking agents
- Other biologic therapies
Contraindications
- Hypersensitivity to abatacept
- Active or dormant untreated tuberculosis
Common side effects
- Headache
- Nausea
- Upper respiratory tract infection
Counselling Points
- Rotate injection sites
- Monitor for infections
- Do not use if pregnant or breastfeeding
Serious warnings
- Risk of serious infections
- Anaphylaxis possible
Important Disclaimer
The Orencia Sc 125 Mg 125 mg Solution for subcutaneous injection professional information leaflet below is the property of Equity Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
